InvestorsHub Logo

Idunno

12/13/20 12:23 PM

#338804 RE: JRIII #338800

Jr111. You keep mentioning “trigger finger”.
Here are the two most important tips, in this regard (imo).

1). Focus! By this I mean Eyes ON The Front Sight. Literally! (Keep the target in the blurry peripheral background).

2). “Let IT surprise you.” By this I mean, when/as you squeeze trigger, move nothing nothin nothing but the trigger finger. Nothing else moves. Eventually, at a point , somewhat, unknown to you, something will go bang. Let that bang be a surprise.

If you follow the above, you will not miss.

moderation23

12/13/20 12:30 PM

#338806 RE: JRIII #338800

Just as a point of fact, Dr. Liau did explicitly mention that she received research funding from NWBO during her talk at UAB.

VuBru

12/13/20 12:32 PM

#338809 RE: JRIII #338800

Means nothing. CME requirements for presenters at talks typically state that brand names of drugs should not be used. Not using the brand name "DCVAX" therefore is totally consistent with this requirement.

Dr Bala

12/13/20 1:06 PM

#338817 RE: JRIII #338800

Not true. LL's slide still says DCVax on that slide in the case of Project 1, which is LL's current combination therapy project.